During the past decade, Institut Curie conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 5 clinical trials were completed, i.e. on average, 7.6% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 2 clinical trials were completed. i.e. 6.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Curie" #1 sponsor was "Institut Curie" with 25 trials, followed by "UNICANCER" with 17 trials sponsored, "Institut Cancerologie de l'Ouest" with 5 trials sponsored, "The Lymphoma Academic Research Organisation" with 5 trials sponsored and "Centre Oscar Lambret" with 5 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Curie" #1 collaborator was "AstraZeneca" with 6 trials as a collaborator, "National Cancer Institute, France" with 4 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Fondation ARC" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Institut Curie" are "Breast Cancer" (17 trials), "Metastatic Breast Cancer" (6 trials), "Ovarian Cancer" (5 trials), "Cancer" (3 trials) and "Fallopian Tube Cancer" (3 trials). Many other conditions were trialed in "Institut Curie" in a lesser frequency.

Most popular intervention types in "Institut Curie" are "Drug" (54 trials), "Other" (19 trials), "Procedure" (13 trials), "Radiation" (5 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (5 trials), "Bevacizumab" (4 trials), "Biopsy" (4 trials), "Placebo" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Institut Curie" are 63 trials for "All" genders, 29 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Institut Curie". undefined are not yet recruiting, 32 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Institut Curie, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Curie, 5 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 28 trials that are defined as “Not Applicable".